|
Feb 6
|
Agios to Webcast Conference Call of Fourth Quarter and Full Year 2024 Financial Results on February 13, 2025
|
|
Jan 3
|
How to Navigate the Stock and Bond Markets in 2025
|
|
Jan 3
|
Agios to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025
|
|
Dec 10
|
Here's Why Agios Stock Plummeted More Than 20% on Monday
|
|
Dec 10
|
Agios Pharmaceuticals price target raised to $75 from $53 at Scotiabank
|
|
Dec 6
|
Why Is Denali Therapeutics (DNLI) Down 21.2% Since Last Earnings Report?
|
|
Dec 5
|
Are Options Traders Betting on a Big Move in Agios (AGIO) Stock?
|
|
Dec 5
|
Zacks Industry Outlook Highlights ResMed, Haemonetics, Phibro and Agios
|
|
Dec 4
|
4 Medical Product Stocks to Buy From a Prospective Industry
|
|
Oct 17
|
Agios to Webcast Conference Call of Third Quarter 2024 Financial Results on October 31, 2024
|
|
Sep 27
|
Do Options Traders Know Something About Agios (AGIO) Stock We Don't?
|
|
Sep 26
|
Pfizer Tanked A $5.4 Billion Takeover. Why Crispr, Agios, Beam Could Benefit.
|
|
Sep 6
|
Why Is Zimmer (ZBH) Down 3.9% Since Last Earnings Report?
|
|
Sep 5
|
Agios to Present at the 2024 Cantor Global Healthcare Conference on September 18, 2024
|
|
Jul 29
|
Analysts Estimate Quanterix Corporation (QTRX) to Report a Decline in Earnings: What to Look Out for
|
|
Jul 25
|
Agios Pharmaceuticals (AGIO) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
|
|
Jul 24
|
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Has Found A Path To Profitability
|
|
Jun 24
|
Agios Pharmaceuticals (AGIO) Surges 6.5%: Is This an Indication of Further Gains?
|
|
Jun 15
|
Swelling losses haven't held back gains for Agios Pharmaceuticals (NASDAQ:AGIO) shareholders since they're up 71% over 1 year
|
|
Jun 15
|
Agios Presents Positive Results from Phase 3 ENERGIZE Study of Mitapivat in Non-Transfusion-Dependent Thalassemia in Plenary Session at the European Hematology Association 2024 Hybrid Congress
|